The development and marketing of biologics and vaccines in the U.S. are tightly regulated by the FDA to ensure safety, efficacy, and quality. Compliance with regulatory requirements, including Biologics License Applications (BLA), Investigational New Drug (IND) submissions, and GMP standards, is essential for legal distribution and clinical trial approval. At [...]